| Community Walgreens Pharmacy #16475 | |
| 555 Michigan St Ne, Ste 100, Grand Rapids, Michigan 49503 | |
| (616) 224-0115 |
| Name | Community Walgreens Pharmacy #16475 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 555 Michigan St Ne, Ste 100, Grand Rapids, Michigan 49503 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (616) 224-0115 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Scientists have identified a quantitative method to measure changes in biomarkers, which may reduce or eliminate the need for invasive biopsies. The method, described in the February 2016 issue of The FASEB Journal uses a novel chimera design of DNA and small DNA with a companion contrast agent to allow antibodies to cross cellular membranes.
Limiting the nutrient resources that pathogens depend on for replication could prevent the emergence of drug resistance, according to research findings. In a study published in Proceedings of the National Academy of Sciences, scientists have taken advantage of the competition that occurs between host pathogens to achieve successful treatment of infection with existing drugs, even when drug-resistant pathogens were present.
Medical researchers at the University of Alberta recently published their findings that rats with restricted growth in the womb, causing low birth weights when born, were most susceptible to developing age-related vision loss, compared to their normal weight counterparts.
› Verified 7 days ago
| NPI Number | 1649723263 |
| Organization Name | WALGREEN CO |
| Doing Business As | COMMUNITY, A WALGREENS PHARMACY #16475 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 555 Michigan St Ne Ste 100, Grand Rapids, MI 49503 |
| Phone Number | 616-224-0115 |
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Scientists have identified a quantitative method to measure changes in biomarkers, which may reduce or eliminate the need for invasive biopsies. The method, described in the February 2016 issue of The FASEB Journal uses a novel chimera design of DNA and small DNA with a companion contrast agent to allow antibodies to cross cellular membranes.
Limiting the nutrient resources that pathogens depend on for replication could prevent the emergence of drug resistance, according to research findings. In a study published in Proceedings of the National Academy of Sciences, scientists have taken advantage of the competition that occurs between host pathogens to achieve successful treatment of infection with existing drugs, even when drug-resistant pathogens were present.
Medical researchers at the University of Alberta recently published their findings that rats with restricted growth in the womb, causing low birth weights when born, were most susceptible to developing age-related vision loss, compared to their normal weight counterparts.
› Verified 7 days ago
News Archive
Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).
Scientists have identified a quantitative method to measure changes in biomarkers, which may reduce or eliminate the need for invasive biopsies. The method, described in the February 2016 issue of The FASEB Journal uses a novel chimera design of DNA and small DNA with a companion contrast agent to allow antibodies to cross cellular membranes.
Limiting the nutrient resources that pathogens depend on for replication could prevent the emergence of drug resistance, according to research findings. In a study published in Proceedings of the National Academy of Sciences, scientists have taken advantage of the competition that occurs between host pathogens to achieve successful treatment of infection with existing drugs, even when drug-resistant pathogens were present.
Medical researchers at the University of Alberta recently published their findings that rats with restricted growth in the womb, causing low birth weights when born, were most susceptible to developing age-related vision loss, compared to their normal weight counterparts.
› Verified 7 days ago
Air-caire Home Medical Equipment &s Type: Medicare Supplier Location: 3554 Alpine Ave Nw, Grand Rapids, Michigan 49544 Phone: (616) 888-2056 | |
Airway Oxygen Inc Type: DME Supplier - Parenteral & Enteral Nutrition Location: 2935 Madison Ave Se, Grand Rapids, Michigan 49548 Phone: (616) 247-3900 | |
Airway Oxygen Inc Type: DME Supplier - Parenteral & Enteral Nutrition Location: 5150 Plainfield Avenue, Ne, Grand Rapids, Michigan 49525 Phone: (616) 364-4044 | |
Andersen Eye Prosthetics Llc Type: Medicare Supplier Location: 2757 Leonard St Ne, Grand Rapids, Michigan 49525 Phone: (989) 797-2400 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4513 Broadmoor Seave D, Grand Rapids, Michigan 49512 Phone: (616) 698-9119 |